Recent News

• 04.21.2025 - Invivyd Announces $30M Non-dilutive Loan Facility with Silicon Valley Bank
• 04.21.2025 - Invivyd Announces $30M Non-dilutive Loan Facility with Silicon Valley Bank
• 03.26.2025 - Invivyd Appoints Ajay Royan, Founder of Mithril Capital, to its Board of Directors
• 03.26.2025 - Invivyd Appoints Ajay Royan, Founder of Mithril Capital, to its Board of Directors
• 03.20.2025 - Invivyd Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Recent Business Highlights
• 03.20.2025 - Invivyd Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Recent Business Highlights
• 03.05.2025 - Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1
• 03.05.2025 - Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1
• 02.24.2025 - FDA Declined Invivyd’s Request to Expand Existing Emergency Use Authorization of PEMGARDA™ (pemivibart) to Include Treatment of Mild-to-Moderate COVID-19 For Immunocompromised Persons Who Have No Alternative Therapeutic Options; No Change to the Existing

Recent Filings

• 04.07.2025 - ARS Annual Report to Security Holders
• 04.07.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.07.2025 - DEF 14A Other definitive proxy statements
• 03.26.2025 - 8-K Current report
• 03.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.26.2025 - EX-99.1 EX-99.1
• 03.26.2025 - 3 Initial statement of beneficial ownership of securities
• 03.20.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.20.2025 - 8-K Current report
• 03.05.2025 - 8-K Current report